A Review on the Role of SPRY4-IT1 in the Carcinogenesis

Soudeh Ghafouri-Fard1, Tayyebeh Khoshbakht2, Mohammad Taheri3

  • 1Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Frontiers in Oncology
|January 31, 2022
PubMed

Insights

Sprouty RTK signaling antagonist 4-intronic transcript 1 (SPRY4-IT1), a long non-coding RNA, promotes cancer by regulating cell growth and sequestering microRNAs. Its oncogenic roles are evident across various cancers and signaling pathways.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Sprouty RTK signaling antagonist 4-intronic transcript 1 (SPRY4-IT1) is a long non-coding RNA (lncRNA) involved in regulating cell growth, proliferation, and apoptosis.
  • SPRY4-IT1 plays a role in lipid biosynthesis by controlling lipin 2 levels.
  • This lncRNA exhibits oncogenic properties in various tissues.

Purpose of the Study:

  • To elucidate the role of SPRY4-IT1 in carcinogenesis.
  • To explore the mechanisms by which SPRY4-IT1 contributes to cancer development.
  • To investigate the interactions of SPRY4-IT1 with microRNAs and signaling pathways.

Main Methods:

  • Analysis of cell lines, xenograft models, and clinical studies.
  • Investigation of SPRY4-IT1's interaction with microRNAs (e.g., miR-101-3p).
  • Examination of SPRY4-IT1's functional associations with signaling pathways (e.g., HIF-1α, NF-κB/p65, AMPK, ZEB1, MAPK, PI3K/Akt).

Main Results:

  • SPRY4-IT1 acts as an oncogene in diverse tissues.
  • SPRY4-IT1 sequesters microRNAs, including miR-101-3p, contributing to carcinogenesis.
  • Evidence from cell lines, xenografts, and clinical studies supports SPRY4-IT1's oncogenic role and its interactions with key signaling pathways.

Conclusions:

  • SPRY4-IT1 is implicated in the carcinogenesis process through microRNA sponging and modulation of cellular signaling pathways.
  • The findings highlight SPRY4-IT1 as a potential therapeutic target in various cancers.
  • Further research into SPRY4-IT1's functions can advance our understanding of cancer biology.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.4K